NIR responsive tumor vaccine in situ for photothermal ablation and chemotherapy to trigger robust antitumor immune responses

Abstract Background Therapeutic tumor vaccine (TTV) that induces tumor-specific immunity has enormous potentials in tumor treatment, but high heterogeneity and poor immunogenicity of tumor seriously impair its clinical efficacy. Herein, a novel NIR responsive tumor vaccine in situ (HA-PDA@IQ/DOX HG)...

Full description

Bibliographic Details
Main Authors: Lirong Zhang, Jingjing Zhang, Lixia Xu, Zijian Zhuang, Jingjin Liu, Suwan Liu, Yunchao Wu, Aihua Gong, Miaomiao Zhang, Fengyi Du
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Journal of Nanobiotechnology
Subjects:
Online Access:https://doi.org/10.1186/s12951-021-00880-x